While information sharing is key to cross-country collaborations on access to medicines and can lead to major benefits, it is hard to sell to political leaders and the media, says a report from the World Health Organization’s regional office for Europe.

The European Commission says it will publish its review of the EU orphan drug legislation in the coming days.

The UK has formally withdrawn its ratification of the Unified Patent Court Agreement, adding to the uncertainty over its future.

Brazil’s medicines regulator has published advice for developers on how to proceed with ongoing clinical trials and bioequivalence studies during the current COVID-19 pandemic.

Obscure drug pricing in Europe could help minimize an “access threat” posed by US pricing policies.

The agreement should help Colombia improve its HTA process and access to medicines there.